Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Utah Medical Products (UTMD) Leases (2019 - 2025)

Utah Medical Products has reported Leases over the past 7 years, most recently at $286000.0 for Q4 2025.

  • Quarterly results put Leases at $286000.0 for Q4 2025, down 15.38% from a year ago — trailing twelve months through Dec 2025 was $286000.0 (down 15.38% YoY), and the annual figure for FY2025 was $286000.0, down 15.38%.
  • Leases for Q4 2025 was $286000.0 at Utah Medical Products, down from $338000.0 in the prior quarter.
  • Over the last five years, Leases for UTMD hit a ceiling of $449000.0 in Q4 2021 and a floor of $286000.0 in Q4 2025.
  • Median Leases over the past 5 years was $384000.0 (2021), compared with a mean of $379727.3.
  • Biggest five-year swings in Leases: rose 19.1% in 2021 and later dropped 15.38% in 2025.
  • Utah Medical Products' Leases stood at $449000.0 in 2021, then dropped by 12.03% to $395000.0 in 2022, then fell by 13.42% to $342000.0 in 2023, then dropped by 1.17% to $338000.0 in 2024, then dropped by 15.38% to $286000.0 in 2025.
  • The last three reported values for Leases were $286000.0 (Q4 2025), $338000.0 (Q4 2024), and $342000.0 (Q4 2023) per Business Quant data.